Adjunctive Cenobamate Delivers Sustained Reductions Across Focal Seizure Subtypes in Adults
A multinational phase 3 extension trial demonstrated that adjunctive cenobamate sustained high seizure reductions and notable seizure-free rates across distinct ...


